Activity in this selectionconverge-ventures-315611b4
- Rounds participated in
- 1
- Confirmed lead rounds
- 1
All roles disclosed- New companies
- 1
First participation on record · 0 follow-on- Funding in participating rounds
- $290M
1 disclosed · full round size, not this investor’s share
Rounds
1 in this selectionAnew LabsAn AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.
Lead